AHA and FBI collaborate to address targeted violence in healthcare, offering resources and strategies for threat assessment and management in health care settings.
Pfizer's ABRYSVO RSV vaccine, approved by the FDA, offers broad protection for adults at risk of RSV, including pregnant individuals, based on inferred efficacy from a pivotal Phase 3 trial.
